All In Biotech

Free tool

FAERS Monitor: Technescan Hdp

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018321 or its brand name (Technescan Hdp, Technetium Tc-99m Oxidronate Kit). Reports on generic versions are filed under their own applications.

Reports

136

Serious

68

50% of reports

Hospitalization

18

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea16
  • bone scan abnormal14
  • injection site pain10
  • drug ineffective9
  • headache9
  • injection site swelling8
  • injection site erythema7
  • injection site extravasation7
  • dizziness6
  • product administration error6
  • product preparation issue6
  • radioisotope scan abnormal6
  • vomiting6
  • chest pain5
  • dysgeusia5

Reports by year received

View as table
YearReports
20044
20052
20071
20101
20122
20133
20145
20151
20163
20172
201811
20197
202011
202166
20221
20233
20245
20255
20263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,023 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bone scan abnormalSignal145273.33181.066,361
radioisotope scan abnormalSignal61325.0603.96,613
product preparation issueSignal6141.664.7702
injection site extravasationSignal787.842.7517
product administration errorSignal645.921.0221
injection site swellingSignal816.18.299
dysgeusiaSignal510.44.434
injection site erythemaSignal78.74.241
injection site painSignal105.02.829
chest painSignal54.21.89
nauseaSignal163.12.022
headacheSignal92.21.25
vomiting62.00.92
dizziness61.90.92
drug ineffective91.10.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.